vimarsana.com

Page 21 - தலை ஆஃப் முதலீட்டாளர் உறவுகள் பெருநிறுவன தகவல்தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sensorion to Attend Two Conferences in June 2021

Idorsia Pharmaceuticals Ltd: European Commission approves Ponvory (ponesimod) for the treatment of adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features

Idorsia Pharmaceuticals Ltd: European Commission approves Ponvory (ponesimod) for the treatment of adults with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features , 2021 Idorsia Ltd (SIX: IDIA) was informed by the Janssen Pharmaceutical Companies of Johnson & Johnson that the European Commission (EC) has approved Ponvory?(ponesimod) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features. Idorsia and Actelion Pharmaceuticals Ltd, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, have entered into a revenue-sharing agreement in respect to ponesimod. Under the terms of the revenue-sharing agreement, Idorsia is entitled to receive quarterly payments of 8% of the net sales of ponesimod products from Actelion.

Idorsia holds its Annual General Meeting of Shareholders

Idorsia holds its Annual General Meeting of Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Idorsia Pharmaceuticals Ltd: Idorsia holds its Annual General Meeting of Shareholders

Idorsia Pharmaceuticals Ltd: Idorsia holds its Annual General Meeting of Shareholders All Board proposals approved by the Shareholders At today s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Allschwil, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with a large majority. The meeting was held in accordance with the requirements of the COVID-19 Ordinance 3, issued by the Swiss Federal Council. As a result, attendance in person was not possible and voting took place by independent proxy. In total, 4,541 shareholders voted through the independent proxy, representing a total of 112,170,657 shares, or 67.13% of the total outstanding shares.

Integer Wealth Advisors Group To Join Focus Partner Firm JFS Wealth Advisors Transaction will Increase JFS Scale and Enhance Its East Coast Presence

Integer Wealth Advisors Group To Join Focus Partner Firm JFS Wealth Advisors Transaction will Increase JFS Scale and Enhance Its East Coast Presence
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.